Flow cytometry in the diagnosis of peritoneal carcinomatosis

American Journal of Gastroenterology

Volumn 96, Issue 5, 2001, Pages 1605-1609

  Both, Cristiane Tovo ^a   Mattos, Angelo Alves De ^a   Neumann, Jorge ^b   Reis, Marciano D ^c  

^a Santa Casa Complexo Hospitalar   (Brazil)

^b Santa Casa Complexo Hospitalar   (Brazil)

^c SUNNYBROOK RESEARCH INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

ADOLESCENT; ADULT; AGED; ARTICLE; ASCITES; BRAZIL; CARCINOMATOUS PERITONITIS; CHILD; CONTROLLED STUDY; CYTOPATHOLOGY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LYMPHOCYTE; MAJOR CLINICAL STUDY; MALE; PARAMETER; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY;

EID: 0342936458     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9270(01)02348-6     Document Type: Article

References (56)

1. Barlogie B., Drewinko B., Schumann J., et al. Cellular DNA content as a marker of neoplasia in man. Am J Med. 69:1980;195-203.
2. Dewald G., Dines D.E., Weiland L.H., Gordon H. Usefulness of chromossome examination in the diagnosis of malignant pleural effusions. N Engl J Med. 29:1976;1494-1500.
3. Givan A.L. Flow cytometry First principles . 1992;Wiley-Liss, New York.
4. Hedley D.W., Shankey T.V., Wheeless L.L. DNA cytometry consensus conference. Cytometry. 14:1993;471.
5. Jones M.A., Hitchcox S., D'Ascanio P., et al. Flow cytometric DNA analysis versus cytology in the evaluation of peritoneal fluids. Gynecol Oncol. 43:1991;226-232.
6. Shankey T.V., Rabinovitch P.S., Bagwell B., et al. Guidelines for implementation of clinical DNA cytometry. Cytometry. 14:1993;472-477.
7. Mattos A.A. Biópsia peritoneal às cegas. Rev AMRIGS. 27:1983;288-293.
8. Mattos A.A., Lima J.P. Estudo do líquido de ascite. Rev AMRIGS. 27:1983;294-301.
9. Mattos A.A., Lima J.P., Vilela M.P. Contribuição do exame citopatológico do peritônio no diagnóstico da carcinomatose peritoneal. GED. 12:1993;13-22.
10. Runyon B.A. Ascites and spontaneous bacterial peritonitis. Sleisenger M.H., Fordtran J.S. Gastrointestinal disease. 6th ed :1998;1310-1333 WBSC, Philadelphia.
11. Berge T., Hellsten S. Cytological diagnosis of cancer cell in pleural and ascitic fluid; comparision of results obtained by pathologist and cytologist. Acta Cytol. 10:1966;138-140.
12. Decker A., Bupp P.A. An investigation into the usefulness of cell block versus smears. Am J Clin Pathol. 70:1978;855-860.
13. Johnson W.D. The cytological diagnosis of cancer in serum effusions. Acta Cytol. 10:1966;161-172.
14. Koss L.G. Diagnostic cytology and its histological bases. 3rd ed. 1979;Lippincott, Philadelphia.
15. Luse A.S., Reagan J.W. A histocytological study of effusions. effusions associated with malignant tumors. Cancer. 7:1954;1167-1181.
16. Evans D.A., Thornthwaite J.T., Ng A.B.P. DNA flow cytometry of pleural effusions. Comparision with pathology for the diagnosis of malignancy. Anal Quant Cytol Histol. 5:1983;19-27.
17. Rijken A., Dekker A., Taylor S., et al. Diagnostic value of DNA analysis in effusions by flow cytometry and image analysis. Am J Clin Pathol. 95:1991;6-12.
18. Ross J.S. DNA ploidy, and cell cycle analysis in pathology. 1996;Igaku Shoin Medical, New York.
19. Sahni K., Tribukait B., Einharn N. Flow cytometric measurement of ploidy and proliferation in effusions of ovarian carcinoma and their possible prognostic significance. Gynecol Oncol. 35:1989;240-245.
20. Schneller J., Eppich E., Greenebaum E. Flow cytometry and feulgen cytophotometry in evaluation of effusions. Cancer. 59:1987;1307-1313.
21. Unger K., Raber M., Bedrosain C.W.M., et al. Analysis of pleural effusions using automated flow cytometry. Cancer. 52:1983;873-877.
22. Weissman G.S., McKinley M.J., Budmann D.R., et al. Flow cytometry - a new technique in the diagnosis of malignant ascites. J Clin Gastroenterol. 9:1987;599-602.
23. Zarbo R.J. Flow cytometric DNA analysis of effusion. Am J Clin Pathol. 95:1991;2-4. (editorial).
24. Bales C.E., Durfee G.R. Cytologic techniques. Koss L.G. Diagnostic cytology and its histopathologic bases. 3rd ed. 1979;1187-1266 Lippincott, Philadelphia.
25. Prolla G., Preger R., Fleck J. A cinética celular. Fleck J. Câncer Integração clínico-biológica . 1992;123-142 Medsi, Rio de Janeiro.
26. Riley R.S., Mahin E.J., Ross W. Clinical applications of flow cytometry. 1993;Igaku Shoin Medical, New York.
27. Shapiro H.M. Practical flow cytometry. 3rd ed. 1995;Wiley-Liss, New York.
28. Joseph M.G., Banerjee D., Harris P., et al. Multiparameter flow cytometric DNA analysis of effusions A prospective study of 36 cases compared with routine cytology and immunohistochemistry . Mod Pathol. 8:1995;686-693.
29. Cibas E.S. Applications of flow cytometric DNA analysis to diagnostic cytology. Diagn Cytopathol. 13:1995;166-171.
30. Fuhr J.E., Kattine A.A., Sullivan T.A., Nelson H.S. Flow cytrometric analysis of pulmonary fluids and cells for the detection of malignancies. Am J Pathol. 141:1992;211-215.
31. Green L.K., Griffin J. Increased natural killer cells in fluids. A new, sensitive means of detecting carcinoma. Acta Cytol. 40:1996;1240-1245.
32. O'Leary T.J. Flow cytometry in diagnostic cytology. Diagn Cytopathol. 18:1998;41-46.
33. Orfao A., Ciudad J., Gonzalez M., et al. Flow cytometry in the diagnosis of cancer. Scand J Clin Lab Invest. 221:1995;145-152.
34. Ceyhan B.B., Demiralp E., Celikel T. Analysis of pleural effusions using flow cytometry. Respiration. 63:1996;17-24.
35. Hedley D.W., Philips J., Rugg C.A. Measurement of cellular DNA content as an adjunct to diagnostic cytology in malignant effusions. Eur J Cancer Clin Oncol. 20:1984;749-752.
36. Hostmark J., Vigander T., Skaarland E. Characterization of pleural effusions by flow-cytometric DNA analysis. Eur J Respir Dis. 66:1985;315-319.
37. Kapusta L., Zbieranowski I., Demianiuk C. The role of DNA flow and image cytometry in the evaluation of body cavity fluids. Anal Quant Cytol Histol. 13:1991;187-192.
38. Katz R.L., Johnson T.S., Williamson K.D. Comparision of cytologic and acridine-orange flow-cytometric detection of malignant cells in human body cavity fluids. Anal Quant Cytol Histol. 7:1985;227-235.
39. Sinton E.B., Carver R.K., Morgan D.L. Prospective study of concurrent ploidy analysis and routine cytopathology in body cavity fluids. Arch Pathol Lab Med. 114:1990;188-194.
40. Palmer H.E., Wilson C.S., Bardales R.H. Cytology and flow cytometry of malignant effusions of multiple myeloma. Diagn Cytopathol. 229:2000;147-151.
41. Tavel M.E. Ascites Etiologic considerations with emphasis on the value of several laboratory findings in diagnosis . Am J Med Sci. 237:1959;727-733.
42. Ghilain J.M., Henrion J., Schapira M., et al. Le liquid d'ascite: intérêt de divers tests biologiques dans le diagnostic différential entre ascite cirrhotique et néoplasique. Acta Gastroenterol Belg. 53:1990;168-179.
43. Mattos A.A. Ascite. 1994;Byk, Porto Alegre, Brazil.
44. McGuckin W.F., Soule E.H., Cain J.C. The value of glycoprotein determination and cytology in the study of ascitic fluid. Gastroenterology. 37:1959;332-338.
45. Ceelen G.H. The cytologic diagnosis of ascitic fluid. Symposium on diagnostic accuracy of cytologic technics. Acta Cytol. 8:1964;165-185.
46. Luse A.S. A hystocytologic and electron microscopic study of effusions associated with malignant disease. Ann N Y Acad Sci. 63:1956;1331-1347.
47. Von Haam E. A comparative study of the accuracy of cancer cell detection by cytological methods. Acta Cytol. 6:1962;508-518.
48. Sikora J., Dvoracki G., Zeromnski J. DNA ploidy, S-phase, and Ki-67 antigen expression in the evaluation of cell content of pleural effusions. Lung. 174:1996;303-313.
49. Kehoe S., Ward K., Luesley D., Chan K.K. The application of flow cytometric DNA analysis in detecting the presence of malignant cells in ovarian carcinoma peritoneal fluids. Br J Obstet Gynaecol. 102:1995;656-659.
50. Banks E.R., Jennings C.D., Jacobs S., Davey D.D. Comparative assessment of DNA analysis in effusions by image analysis and flow cytometry. Diagn Cytopathol. 10:1994;62-67.
51. Bardales R.H., Stanley M.W., Schaefer R.F., et al. Secondary pericardial malignancies. A critical appraisal of the role of cytology, pericardial biopsy and DNA ploidy analysis. Am J Clin Pathol. 106:1996;29-34.
52. Frierson H.F. Ploidy and proliferative fraction analysis of cytologic specimens. Keren D.F., Hanson C.A., Hurtubise P.E. Flow cytometry and clinical diagnosis. 1994;596-613 American Society of Clinical Pathologists, Chicago.
53. Saha I., Dey P., Vhora H., Nijhawan R. Role of DNA flow cytometry and image cytometry on effusion fluid. Diagn Cytol. 22:2000;81-85.
54. Lee J.S., Lee M.C., Park C.S., Juhng S.W. Diagnostic value of p53 protein and flow cytometric DNA analysis in the study of serous effusions. Acta Cytol. 41:1997;1719-1725.
55. Clark G.M., Mathieu M.C., Owens M.A., et al. Prognostic significance of S-phase fraction in good-risk, node-negative breast cancer patients. J Clin Oncol. 10:1992;428-432.
56. Joensuu H., Kallioniemi O.P. Different opinions on classification of DNA histograms produced from paraffin-embedded tissue. Cytometry. 10:1989;711-717.